Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Public-private partnerships need honest brokering

Nature Medicine volume 18, page 341 (2012)Cite this article

Subjects

Given the current challenges in research and development, it's increasingly apparent that collaboration between large pharmaceutical companies, academic teams and biotechnology enterprises is essential for converting basic biomedical discoveries into lifesaving medicines. But these partnerships work best when a neutral third party helps foster them.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Melese, T., Lin, S.M., Chang, J.L. & Cohen, N.H. Nat. Med. 15, 502–507 (2009).

    Article  CAS  Google Scholar 

  2. Woodcock, J. & Woosley, R. Annu. Rev. Med. 59, 1–12 (2008).

    Article  CAS  Google Scholar 

  3. Strauss, S. Nat. Biotechnol. 28, 631–634 (2010).

    Article  CAS  Google Scholar 

  4. Ravassard, P. et al. J. Clin. Invest. 121, 3589–3597 (2011).

    Article  CAS  Google Scholar 

  5. Pardoe, D., Hunter, J. & Cooke, R. Drug Discov. World 12, 9–17 (2011).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michel Goldman is the executive director of the Innovative Medicine Initiative in Brussels, Belgium. The opinions expressed in this article do not necessarily reflect the positions and opinions of the European Commission or the European Federation of Pharmaceutical Industries and Associations.,

    Michel Goldman

Authors
  1. Michel Goldman
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldman, M. Public-private partnerships need honest brokering. Nat Med 18, 341 (2012). https://doi.org/10.1038/nm0312-341

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0312-341

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing